Free Trial
OTCMKTS:ESMC

Escalon Medical Q1 2026 Earnings Results & Report

Escalon Medical logo
$0.15 0.00 (0.00%)
As of 10/9/2026

Escalon Medical reported Q1 2026 earnings on November 14, 2025. The company reported EPS of -$0.03, while revenue was $2.67 million.

Earnings Announcement Details

Quarter
Q1 2026
Time
After Market Closes

Escalon Medical EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Escalon Medical Revenue Results

Actual Revenue
$2.67 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Escalon Medical Q1 2026 Earnings FAQ

Escalon Medical (OTCMKTS:ESMC) reported earnings of -$0.03 per share for Q1 2026. The report was announced on Friday, November 14, 2025.

Escalon Medical reported revenue of $2.67 million for Q1 2026.

Escalon Medical Earnings Headlines

Escalon Medical Corp
What’s Elon building now?
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.tc pixel
Escalon Medical Delays Annual 10-K Filing
See More Escalon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Escalon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Escalon Medical and other key companies, straight to your email.

About Escalon Medical

Escalon Medical (OTCMKTS:ESMC) is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.

Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.

Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally. Publicly available information about the company’s current operations, leadership and geographic reach is limited, and its product portfolio and corporate structure may have changed over time.

View Escalon Medical Profile